1. Non-coding RNAs underlying chemoresistance in gastric cancer
   Arash Poursheikhani et al, 2020, Cellular Oncology CrossRef
2. LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis
   Yufen Xu et al, 2024, Expert Review of Anticancer Therapy CrossRef
3. Multifaceted role of microRNAs in gastric cancer stem cells: Mechanisms and potential biomarkers
   Qian-Hui Sun et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
4. miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer
   Kha Wai Hon et al, 2018, Frontiers in Pharmacology CrossRef
5. Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429
   Xiaofeng Wang et al, 2022, Frontiers in Genetics CrossRef
6. miRNAs as Biomarkers and Possible Therapeutic Strategies in Synovial Sarcoma
   Shaowei Jiang et al, 2022, Frontiers in Pharmacology CrossRef
7. Inhibition of microRNA-17 enhances cisplatin-induced apoptosis of human tongue squamous carcinoma cell
   Yang Sun et al, 2021, Journal of Bioenergetics and Biomembranes CrossRef
8. Gamma Knife Radiosurgery Modulates micro-RNA Levels in Patients with Brain Metastasis
   Imran Khan et al, 2023, Current Radiopharmaceuticals CrossRef
9. Role of microRNAs in drug resistance of gastric cancer cells
   Bi-Bo Tan et al, 2019, World Chinese Journal of Digestology CrossRef
10. Non-coding RNA in drug resistance of gastric cancer
    Ya-Jun Luo et al, 2019, World Journal of Gastrointestinal Oncology CrossRef
11. MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma
    Wei Dong et al, 2021, OncoTargets and Therapy CrossRef